Certolizumab
UCB Pharmaceuticals
['axspa']
#acr22 abs 0408 et al, nr-axspa pts achieving long-term clinical outcomes w/ czp tx after 1 yr were generally sustained over 3 yrs across mri+/crp+, mri /crp+ and mri+/crp subgroups; asdas-mi numerically highest in mri+/crp+. 
Passionately curious rheumatologist, world traveler, wife, mother, sister, daughter, friend, dog lover. Believer in scientific method & evidence based medicine.